메뉴 건너뛰기




Volumn 33, Issue 1, 2017, Pages 22-26

Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference

Author keywords

Daratumumab; Interference; Pre transfusion testing

Indexed keywords

DARATUMUMAB; DITHIOTHREITOL; MACROGOL; SODIUM CHLORIDE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

EID: 85021854606     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (9)

References (10)
  • 1
    • 84953325096 scopus 로고    scopus 로고
    • Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
    • Lonial S, Weiss BM, Usmani SZ, et al. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Lancet 2016;387:1551-60
    • (2016) Lancet , vol.387 , pp. 1551-1560
    • Lonial, S.1    Weiss, B.M.2    Usmani, S.Z.3
  • 2
    • 84978154089 scopus 로고    scopus 로고
    • New mAb therapies in multiple myeloma: interference with blood transfusion compatibility testing
    • De Vooght KMK, Oostendorp M, Van Solinge WW. New mAb therapies in multiple myeloma: interference with blood transfusion compatibility testing. Curr Opin Hematol 2016;23:557-62
    • (2016) Curr Opin Hematol , vol.23 , pp. 557-562
    • De Vooght, K.M.K.1    Oostendorp, M.2    Van Solinge, W.W.3
  • 3
    • 84931577511 scopus 로고    scopus 로고
    • Resolving the daratumumab interference with blood compatibility testing
    • Chapuy CI, Nicholson RT, Aguad MD, et al. Resolving the daratumumab interference with blood compatibility testing. Transfusion 2015;55:1545-54
    • (2015) Transfusion , vol.55 , pp. 1545-1554
    • Chapuy, C.I.1    Nicholson, R.T.2    Aguad, M.D.3
  • 4
    • 84959423326 scopus 로고    scopus 로고
    • Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma
    • van de Donk NW, Moreau P, Plesner T, et al. Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma. Blood 2016;127:681-96
    • (2016) Blood , vol.127 , pp. 681-696
    • van de Donk, N.W.1    Moreau, P.2    Plesner, T.3
  • 5
    • 0029909008 scopus 로고    scopus 로고
    • CD38: a cell-surface protein with multiple functions
    • Mehta K, Shahid U. CD38: a cell-surface protein with multiple functions. FASEB J 1996;10:1408-17
    • (1996) FASEB J , vol.10 , pp. 1408-1417
    • Mehta, K.1    Shahid, U.2
  • 7
    • 84987788894 scopus 로고    scopus 로고
    • International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing
    • Chapuy CI, Aguad MD, Nicholson RT, et al. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing. Transfusion 2016;12: 2964-72
    • (2016) Transfusion , vol.12 , pp. 2964-2972
    • Chapuy, C.I.1    Aguad, M.D.2    Nicholson, R.T.3
  • 8
    • 84871540776 scopus 로고    scopus 로고
    • Immunohematology
    • Hutchinson R, McPherson R, Schexneider K, eds. 22nd ed. Philadelphia, PA: Elsevier Saunders
    • Cooling L, Downs T. Immunohematology. In: Hutchinson R, McPherson R, Schexneider K, eds. Henry's clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia, PA: Elsevier Saunders 2011:674-730
    • (2011) Henry's clinical diagnosis and management by laboratory methods , pp. 674-730
    • Cooling, L.1    Downs, T.2
  • 9
    • 84941776674 scopus 로고    scopus 로고
    • An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab
    • Schmidt AE, Kirkley S, Patel N, et al. An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab. Transfusion 2015;55:2292-3
    • (2015) Transfusion , vol.55 , pp. 2292-2293
    • Schmidt, A.E.1    Kirkley, S.2    Patel, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.